Stock listing

Munich:MYD Myriad Genetics, Inc. Aktie

German listing (Munich) of Myriad Genetics, Inc. · home listing NASDAQ:MYGN

Follow Myriad Genetics, Inc. into a list and get an email when it puts out news.

Share price · MUN:MYD

€5.31 EUR +0.26 (+5.2%)

Close on Oct 27, 2026

Day range
€5.31 – €5.31 EUROct 27, 2026
Market cap
€2.47B EURAt the close on Oct 27, 2026 · price × 466.1M shares outstanding
Myriad Genetics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MYGN · Home$6.35 USD-0.32 (-4.8%)1,500,611$6.51$6.66$6.285$6.67Close on Oct 30, 2026
LSE:0K3W$6.31 USD+0.567 (+9.9%)5,603$6.09$6.31$6.013$5.743Close on Oct 27, 2026
Frankfurt:MYD€5.842 EUR+0.534 (+10.1%)—€5.842€5.842€5.842€5.308Close on Oct 30, 2026
Dusseldorf:MYD€5.59 EUR+0.012 (+0.2%)—€5.868€5.868€5.59€5.578Close on Oct 30, 2026
Hamburg:MYD€5.658 EUR+0.076 (+1.4%)—€5.878€5.878€5.658€5.582Close on Oct 30, 2026
Munich:MYD€5.308 EUR+0.262 (+5.2%)—€5.308€5.308€5.308€5.046Close on Oct 27, 2026
Ticker
Munich:MYD
Asset type
Stock
Exchange
Munich
Currency
EUR

What changed lately

Calls

Upcoming

  • Myriad Genetics (NASDAQ:MYGN) Q3 2026 Earnings Call

    Wed, Nov 04, 2026 · 4:30 PM ET

    Register

Replays

  • Myriad Genetics (NASDAQ:MYGN) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 4:30 PM ET

    Watch Transcript

  • Myriad Genetics (NASDAQ:MYGN) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 4:30 PM ET

    Watch Transcript

  • Myriad Genetics (NASDAQ:MYGN) Q4 2025 Earnings Call

    Mon, Feb 23, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers

Oct 22, 2026

Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp

Oct 20, 2026

Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026

Oct 15, 2026

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Oct 8, 2026

Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Oct 8, 2026

Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial

Sep 16, 2026

Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference

Aug 27, 2026

Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability

Jul 30, 2026

Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026

Jul 23, 2026

Myriad Genetics Launches FirstGene® Multiple Prenatal Screen

Jul 21, 2026

All Myriad Genetics, Inc. news

Decks

Myriad Genetics, Inc. on 6ix

News releases
39 in the last 12 months · 294 in all · newest Oct 22, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Jul 30, 2026
Decks
47 decks · latest May 5, 2026

Where Myriad Genetics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MYGN · Home listingNASDAQUnited StatesUSD
gettex:MYDgettexGermanyEUR
Lang & Schwarz:897518Lang & SchwarzGermanyEUR
LS Exchange:897518LS ExchangeGermanyEUR
LSE:0K3WLSEUnited KingdomUSD
Frankfurt:MYDFrankfurtGermanyEUR
BOATS:MYGNBOATSUnited StatesUSD
Hanover:MYDHanoverGermanyEUR
BX Swiss:MYDBX SwissSwitzerlandCHF
Dusseldorf:MYDDusseldorfGermanyEUR
Hamburg:MYDHamburgGermanyEUR
Munich:MYD · This pageMunichGermanyEUR
Stuttgart:MYDStuttgartGermanyEUR
Tradegate:MYDTradegateGermanyEUR
Xetra:MYDXetraGermanyEUR

Log in to ask 6ix AI your own questions about Myriad Genetics, Inc.